Complete remission in a patient with angiosarcoma by the combination of OK-432, rhIL-2, and radiotherapy.
Inaba
Tomoko
T
Yamanaka
Kei-Ichi
K
Asahi
Kunihiko
K
Omoto
Youichi
Y
Isoda
Kenichi
K
Hurwitz
Daniel
D
Kupper
Thomas S
TS
Mizutani
Hitoshi
H
D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D006394:Hemangiosarcoma / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage*; D010844:Picibanil / Q000008:administration & dosage*; D011994:Recombinant Proteins / Q000008:administration & dosage; D012074:Remission Induction; D012878:Skin Neoplasms / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*
D000970:Antineoplastic Agents; D007376:Interleukin-2; D011994:Recombinant Proteins; D010844:Picibanil